SteegersEA, von DadelszenP, DuvekotJJ, PijnenborgR. Pre-eclampsia. Lancet, 2010; 376:631–644.
2.
KleinrouwelerCE, WiegerinckMM, Ris-StalpersC, et al.; EBM CONNECT Collaboration. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1, and soluble endoglin in the prediction of pre-eclampsia: A systematic review and meta-analysis. BJOG, 2012; 119:778–787.
3.
DuvekotJJ, CheriexEC, PietersFA, MenheerePP, PeetersLH. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol, 1993; 169:1382–1392.
4.
CuiY, WangW, DongN, et al.Role of corin in trophoblast invasion and uterine spiral artery remodeling in pregnancy. Nature, 2012; 484:246–250.
5.
StepanianA, AlcaïsA, de ProstD, et al; ECLAXIR Study Group. Highly significant association between two common single nucleotide polymorphisms in CORIN gene and preeclampsia in Caucasian women. PLoS One, 2014; 9:e113176.
6.
LiuY, HuJ, YuQ, ZhangP, HanX, PengH. Increased serum soluble corin in mid pregnancy is associated with hypertensive disorders of pregnancy. J Womens Health, 2015; 24:572–577.
7.
KhalilA, MaizN, Garcia-MandujanoR, ElkhouliM, NicolaidesKH. Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia. Ultrasound Obstet Gynecol, 2015; 45:190–198.
